rs2290770

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_199242.3(UNC13D):​c.1977C>T​(p.Thr659Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0138 in 1,614,026 control chromosomes in the GnomAD database, including 2,047 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.027 ( 259 hom., cov: 33)
Exomes 𝑓: 0.012 ( 1788 hom. )

Consequence

UNC13D
NM_199242.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.00

Publications

12 publications found
Variant links:
Genes affected
UNC13D (HGNC:23147): (unc-13 homolog D) This gene encodes a protein that is a member of the UNC13 family, containing similar domain structure as other family members but lacking an N-terminal phorbol ester-binding C1 domain present in other Munc13 proteins. The protein appears to play a role in vesicle maturation during exocytosis and is involved in regulation of cytolytic granules secretion. Mutations in this gene are associated with familial hemophagocytic lymphohistiocytosis type 3, a genetically heterogeneous, rare autosomal recessive disorder. [provided by RefSeq, Jul 2008]
UNC13D Gene-Disease associations (from GenCC):
  • familial hemophagocytic lymphohistiocytosis 3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
  • hereditary hemophagocytic lymphohistiocytosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.36).
BP6
Variant 17-75834935-G-A is Benign according to our data. Variant chr17-75834935-G-A is described in ClinVar as Benign. ClinVar VariationId is 263220.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.264 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
UNC13DNM_199242.3 linkc.1977C>T p.Thr659Thr synonymous_variant Exon 21 of 32 ENST00000207549.9 NP_954712.1 Q70J99-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
UNC13DENST00000207549.9 linkc.1977C>T p.Thr659Thr synonymous_variant Exon 21 of 32 1 NM_199242.3 ENSP00000207549.3 Q70J99-1

Frequencies

GnomAD3 genomes
AF:
0.0273
AC:
4159
AN:
152126
Hom.:
259
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0511
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00884
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.277
Gnomad SAS
AF:
0.0244
Gnomad FIN
AF:
0.0170
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00188
Gnomad OTH
AF:
0.0216
GnomAD2 exomes
AF:
0.0302
AC:
7581
AN:
251390
AF XY:
0.0282
show subpopulations
Gnomad AFR exome
AF:
0.0494
Gnomad AMR exome
AF:
0.00385
Gnomad ASJ exome
AF:
0.00119
Gnomad EAS exome
AF:
0.285
Gnomad FIN exome
AF:
0.0150
Gnomad NFE exome
AF:
0.00271
Gnomad OTH exome
AF:
0.0142
GnomAD4 exome
AF:
0.0124
AC:
18167
AN:
1461782
Hom.:
1788
Cov.:
34
AF XY:
0.0126
AC XY:
9143
AN XY:
727186
show subpopulations
African (AFR)
AF:
0.0505
AC:
1691
AN:
33480
American (AMR)
AF:
0.00371
AC:
166
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.000995
AC:
26
AN:
26136
East Asian (EAS)
AF:
0.283
AC:
11236
AN:
39700
South Asian (SAS)
AF:
0.0212
AC:
1825
AN:
86258
European-Finnish (FIN)
AF:
0.0149
AC:
794
AN:
53326
Middle Eastern (MID)
AF:
0.00381
AC:
22
AN:
5768
European-Non Finnish (NFE)
AF:
0.00112
AC:
1247
AN:
1112008
Other (OTH)
AF:
0.0192
AC:
1160
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
1121
2241
3362
4482
5603
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
250
500
750
1000
1250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0273
AC:
4153
AN:
152244
Hom.:
259
Cov.:
33
AF XY:
0.0295
AC XY:
2195
AN XY:
74432
show subpopulations
African (AFR)
AF:
0.0509
AC:
2115
AN:
41542
American (AMR)
AF:
0.00883
AC:
135
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.276
AC:
1429
AN:
5176
South Asian (SAS)
AF:
0.0247
AC:
119
AN:
4824
European-Finnish (FIN)
AF:
0.0170
AC:
181
AN:
10622
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00188
AC:
128
AN:
68012
Other (OTH)
AF:
0.0209
AC:
44
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
184
369
553
738
922
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
52
104
156
208
260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00790
Hom.:
60
Bravo
AF:
0.0301
Asia WGS
AF:
0.118
AC:
409
AN:
3478
EpiCase
AF:
0.00104
EpiControl
AF:
0.00184

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Familial hemophagocytic lymphohistiocytosis 3 Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.36
CADD
Benign
6.4
DANN
Benign
0.77
PhyloP100
0.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.13
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2290770; hg19: chr17-73831016; COSMIC: COSV52883519; COSMIC: COSV52883519; API